How has been the historical performance of Artemis Medicare?

Oct 01 2025 10:45 PM IST
share
Share Via
Artemis Medicare has experienced significant growth in net sales, increasing from 408.40 Cr in March 2021 to 936.92 Cr in March 2025, alongside a rise in profit after tax to 82.63 Cr. Despite fluctuations in operating profit, the company has shown a positive trend in revenue and profitability, with total assets growing from 586.44 Cr to 1,357.41 Cr during the same period.
Answer:
The historical performance of Artemis Medicare has shown significant growth in net sales and profitability over the years, particularly from March 2021 to March 2025.

Breakdown:
Artemis Medicare's net sales have increased from 408.40 Cr in March 2021 to 936.92 Cr in March 2025, reflecting a strong upward trend. The total operating income followed a similar trajectory, rising from 408.40 Cr in March 2021 to 936.92 Cr in March 2025. Operating profit, however, saw fluctuations, with a notable increase to 140.05 Cr in March 2024 before dropping to 0.00 Cr in March 2025, while profit before tax peaked at 107.00 Cr in March 2025. The profit after tax also demonstrated growth, reaching 82.63 Cr in March 2025, up from 6.49 Cr in March 2021. The company's total assets grew significantly from 586.44 Cr in March 2020 to 1,357.41 Cr in March 2025, indicating robust expansion. Total liabilities also increased, but the company's shareholder's funds rose sharply from 320.19 Cr in March 2021 to 837.68 Cr in March 2025. Cash flow from operating activities improved to 145.00 Cr in March 2025, while cash and cash equivalents at the end of the period stood at 41.00 Cr, up from 11.00 Cr in March 2020. Overall, Artemis Medicare has shown a positive trend in revenue and profitability, despite some fluctuations in operating profit margins.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News